Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition

Autor: Stacey L. Edwards, Michael B. Petersen, Kristine M. Hillman, Vasanthanathan Poongavanam, Maja Marušič, Janez Plavec, Rikke Leth-Larsen, Rakesh N. Veedu, Kislay Roy, Jesper Wengel, Jagat R. Kanwar, Neerati Prasad
Rok vydání: 2015
Předmět:
Vascular Endothelial Growth Factor A
Aptamers
Nucleotide/chemistry

Guanine
Aptamer
Oligonucleotides
Mice
Nude

Cell Movement/drug effects
Antineoplastic Agents
Breast Neoplasms
Human Umbilical Vein Endothelial Cells/drug effects
Molecular Dynamics Simulation
Catalysis
Cell Proliferation/drug effects
chemistry.chemical_compound
Breast cancer
Breast Neoplasms/drug therapy
In vivo
Cell Movement
Cell Line
Tumor

Antineoplastic Agents/chemistry
Materials Chemistry
medicine
Human Umbilical Vein Endothelial Cells
Animals
Humans
Nucleotide
Locked nucleic acid
Oligonucleotides/chemistry
Cell Proliferation
chemistry.chemical_classification
Oligonucleotide
Chemistry
Cell growth
Metals and Alloys
Vascular Endothelial Growth Factor A/metabolism
General Chemistry
Aptamers
Nucleotide

medicine.disease
Molecular biology
Surfaces
Coatings and Films

Electronic
Optical and Magnetic Materials

Tumor Burden
Molecular Docking Simulation
Ceramics and Composites
Cancer research
Female
Tumor Burden/drug effects
DNA
Zdroj: Edwards, S L, Poongavanam, V, R Kanwar, J, Roy, K, M. Hillman, K, Prasad, N, Leth-Larsen, R, Petersen, M, Marusic, M, Plavec, J, Wengel, J & Veedu, R N 2015, ' Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition ', Chemical Communications, vol. 51, no. 46, pp. 9499-9502 . https://doi.org/10.1039/c5cc02756j
ISSN: 1364-548X
DOI: 10.1039/c5cc02756j
Popis: In this study, we investigated the efficacy of an LNA (locked nucleic acid)-modified DNA aptamer named RNV66 targeting VEGF against various breast cancer cell lines. Our results demonstrate that RNV66 efficiently inhibits breast cancer cell proliferation both in vitro and in vivo. Introduction of LNA nucleotides were crucial for higher efficacy. Furthermore, the binding interaction of RNV66 with VEGF was investigated using molecular dynamic simulations leading to the first computational model of the LNA aptamer-VEGF complex blocking its interaction with VEGF-receptor.
Databáze: OpenAIRE